Case Report
Cavernous sinus thrombosis: A rare and potentially lethal complication of herpes zoster ophthalmicus that can easily be missed
DOI:
https://doi.org/10.7196/SAMJ.2023.v113i8.649Keywords:
cavernous sinus thrombosis, herpes zoster ophthalmicusAbstract
Cavernous sinus thrombosis is a rare life-threatening complication of herpes zoster ophthalmicus (HZO). This case highlights the importance of at least considering the diagnosis in all cases of HZO, as the consequences of missing it can be disastrous.
References
Liesegang TJ. Herpes zoster ophthalmicus: Natural history, risk factors, clinical presentation and
morbidity. Ophthalmology 2008;115(2 Suppl):S3-S12.
Gebo KA, Kolyani R, Moore RD, Polydefkis MJ. The incidence of, risk factors for, and sequelae of
herpes zoster among HIV patients in the highly active antiretroviral therapy era. J Acquir Immune
Defic Syndr 2005;40(2):169-174.
Adepoji FG, Olawumi HO, Adehoya BJ. HIV seropositivity and related eye disease in Utih, Ilorin. Niger
Postgrad Med J 2007;14(2):163-165.
Palexas GN, Welsh NH. Herpes zoster ophthalmicus: An early pointer to HIV positivity in young African
patients. Scand J Immunol Suppl 1992;11:67-68.
Vafai A, Berger M. Zoster in patients infected with HIV: A review. Am J Med Sci 2001;321(6):372-380.
Zaal MJW, Völker-Dieben HJ, D’Amaro J. Prognostic value of Hutchinson’s sign in acute herpes zoster
ophthalmicus. Graefes Arch Clin Exp Ophthalmol 2003;241(3):187-191.
Mehkri Y, Valisno JA, Rivas LF, et al. Management of cavernous sinus thrombosis following herpes
zoster ophthalmicus. Cureus 2022;14(1):e21036.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Neeran Narainswami
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
